Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Search

Top

CQ-ROLL CALL, INC. Washington DC USA

UEI: SLED_A226DAC464772E27

CQ-ROLL CALL, INC. Washington DC USA is a federal contractor, registered under UEI SLED_A226DAC464772E27. It has been awarded $680,009 across 6 federal contracts. Primary work spans Internet Publishing and Broadcasting and Web Search Portals, Unknown NAICS, and Newspaper Publishers. Top awarding agencies include Naval Surface Warfare Center, Department Of Commerce Noaa, and FDA Office Of Acq Grant Svcs.

Contact Information

Registration and classification details

Registration

UEI Code

SLED_A226DAC464772E27

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Naval Surface Warfare Center$225.0K33.1%

Department Of Commerce Noaa$175.0K25.7%

FDA Office Of Acq Grant Svcs$86.3K12.7%

Jmd-Procurement Services Staff$72.0K10.6%

W4LD USA Hecsa$66.6K9.8%

Division 0010$55.2K8.1%

Awards by NAICS

519130 - Internet Publishing and Broadcasting and Web Search Portals$346.7K51%

51112 - Unknown NAICS$175.0K25.7%

511110 - Newspaper Publishers$86.3K12.7%

515210 - Cable and Other Subscription Programming$72.0K10.6%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in CQ-ROLL CALL, INC. Washington DC USA's top NAICS codes and agencies

Pulsed Field Ablation (PFA) System for Non-Clinical Research Use

Solicitation # SSN_CDRH-2026-134633

The U.S. Food and Drug Administration is seeking information from vendors capable of providing a complete, off-the-shelf Pulsed Field Ablation (PFA) system intended for non-clinical research use. The required system must include a PFA generator, compatible catheters, all necessary accessories and cables, on-site installation, startup and operational verification, training, comprehensive documentation, warranty coverage, and ongoing technical support. The system must be FDA-approved or cleared for clinical use in the United States to treat atrial fibrillation or other cardiac arrhythmias, ensuring its technological validity and regulatory compliance. This request is solely for market research and does not obligate the government to proceed with a procurement or issue a formal solicitation. Vendors interested in responding must submit the required Vendor Response Form along with supporting documentation demonstrating their capability to meet all specified requirements by the deadline of August 10, 2026, at 2:30 PM Eastern Time. The solicitation number is SSN_CDRH-2026-134633, and the NAICS code is 334516. All responses should be directed to Iris Johnson at the FDA Office of Acquisition and Grant Services in Rockville, Maryland, with contact information provided for email and phone. This sources sought notice is posted on SAM.gov and is part of the FDA’s effort to evaluate available commercial solutions before potential future procurement actions.

FDA Office Of Acq Grant Svcs

POSTED

about 11 hours ago

DEADLINE

Annual Maintenance of the TESCAN Mira 3 Cryo SEM

Solicitation # NOI-FDA-132749

The contract seeks to renew annual maintenance services for the TESCAN Mira-3 Cryo SEM, covering a base year followed by four optional extension years, with the primary goal of ensuring consistent, timely service for equipment malfunctions and scheduled preventive maintenance to minimize downtime and control operational costs. The scope includes comprehensive support for the Mira-3 XMU system and its critical components such as the in-beam SE detector and motorized retractable scintillator BSED (G3 and G4), with the contractor responsible for supplying all consumables required for repairs and routine upkeep to maintain optimal instrument performance and protect ongoing research timelines. This solicitation, identified as NOI-FDA-132749, was posted on August 5, 2026, with responses due by August 14, 2026, and falls under NAICS code 334516 for laboratory analytical instrument manufacturing. The requirement is issued by the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services, with performance expected in Silver Spring, Maryland, and primary contact led by Aarati Singal and secondary support provided by Sarah Hussain. No small business set-aside is designated, and the contract will be managed from the agency’s office in Rockville, Maryland.

FDA Office Of Acq Grant Svcs

POSTED

about 11 hours ago

DEADLINE

High Purity Germanium Gamma-Ray Spectrometer

Solicitation # FDA-75F40126Q00304

The Food and Drug Administration is soliciting a High Purity Germanium (HPGe) Gamma-Ray Spectrometer system for sample analysis through a combined synopsis-solicitation issued as a Request for Quote under solicitation number FDA-75F40126Q00304. The system must consist of seven specific components including a STD P-Type Coaxial Detector, cryostat dipstick assembly, chamber, aluminum endcap, intelligent preamp, coax detector cold preamp assembly, and a 10-foot cable set, all meeting precise technical specifications such as a relative efficiency of 50–60%, energy resolution no greater than 1.25 keV at 122 keV and 2.2 keV at 1.3 MeV, peak-to-Compton ratio of at least 72:1, and an energy range covering 40 keV to 10 MeV. The instrument must be fully compatible with genie 2000/APEX software, Lynx Multi-Channel Analyzers, and vertical dipstick cryostat detector shields. The contract is a single Firm Fixed Price award with delivery required within six to eight weeks of award, and the system must be shipped FOB Destination with in-side delivery, including all shipping and handling costs in the quoted price. The evaluation will be conducted on a lowest-priced technically acceptable basis, with technical acceptability serving as a pass/fail gate before price comparison. To be considered, offerors must be actively registered in the System for Award Management with a valid Unique Entity Identifier and must submit proposals exclusively by email to Tiffany Gates at tiffany.gates@fda.hhs.gov no later than 1:00 PM EST on August 7, 2026. Proposals must include detailed technical documentation, literature, and brochures demonstrating compliance with all requirements, and any “equal” products must be clearly identified with a narrative explaining how they meet each salient technical characteristic. All submitted documents must be in Microsoft Office formats without macros or executable files, and proprietary information must be clearly marked. The contract requires compliance with Section 508 accessibility standards, necessitating an Accessibility Conformance Report based on the Voluntary Product Accessibility Template, and adherence to the Buy American Act through disclosure of the product’s country of manufacture. A one-year manufacturer’s warranty beginning at government acceptance is mandatory, including unlimited phone and email support, a 72-hour on-site response time for repairs,

FDA Office Of Acq Grant Svcs

POSTED

about 11 hours ago

DEADLINE

Personnel Security and PIV Credentialing SupportThe contract titled Personnel Security and PIV Credentialing Support requires management of contractor onboarding and offboarding processes, maintenance of staff rosters, and enforcement of HHS security training compliance, all aligned with HSPD-12 and OMB M-19-17 standards. It includes the full lifecycle administration of PIV badges, from collection upon entry to return upon separation, ensuring strict adherence to federal identity and access management requirements. The work is to be performed under a subcontract structure for the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services, with a solicitation posted on August 4, 2026, and responses due by August 10, 2026. The NAICS code 561612 classifies this effort under administrative management and general management services, indicating the need for experienced providers skilled in federal personnel security operations and credentialing systems.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Regulatory and Privacy Compliance DocumentationThe contract requires the preparation and ongoing maintenance of critical compliance documents including the Privacy Threshold Assessment, Privacy Impact Assessment, Rules of Behavior, and Incident Response Plan, all must be developed and updated in strict accordance with the Health and Human Services and Food and Drug Administration’s Information Security and Privacy policies. These documents are essential to ensuring regulatory adherence, protecting sensitive health information, and maintaining operational readiness for security incidents within the FDA’s environment. The work is scoped as a subcontract under the Department of Health and Human Services, specifically managed by the FDA Office of Acquisition and Grant Services, with the North American Industry Classification System code 541611 indicating it falls under management consulting services. The solicitation was posted on August 4, 2026, with a firm deadline for responses on August 10, 2026, at 4:00 PM. There is no specified set-aside classification, and no physical place of performance is detailed, suggesting the work may be performed remotely or within the broader federal infrastructure. While no point of contact is provided, the official SAM.gov link offers access to additional details for prospective bidders. The emphasis on alignment with HHS and FDA IS2P standards underscores the necessity of deep familiarity with federal health information governance, risk management, and privacy frameworks in order to successfully fulfill the contract requirements.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Secure Data Management and System Authorization (A&A)The contract requires the development and ongoing maintenance of a secure system compliant with standards for handling Controlled Unclassified Information, including the creation and management of a System Security Plan, Plan of Action and Milestones, and a complete Authorization to Operate package. Continuous compliance is enforced through monthly vulnerability scans and rigorous configuration management practices to ensure the system remains hardened against threats and meets federal security requirements. This effort is critical to sustaining authorization and operational integrity in a regulatory environment where data protection is paramount. Awarded as a subcontract under the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services, the solicitation is categorized under NAICS code 541512 for Computer Systems Design Services. Proposals must be submitted by August 10, 2026, with the opportunity posted on August 4, 2026. The place of performance and point of contact details are unspecified, requiring potential bidders to review the SAM.gov link for further information. The contract does not specify a set-aside type, making it open to all qualified subcontractors regardless of business size or status.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Viral Bioinformatics Sequencing and AnalysisThe contract requires the performance of high-throughput sequencing on Bundibugyo virus samples, followed by comprehensive genomic analysis and data interpretation to inform and support public health response efforts. The work demands precision in sample processing, accurate sequencing, and robust bioinformatics to extract actionable insights from viral genomic data. All results must be delivered in compliance with standards set by the FDA-ARGOS program, including both finalized analytical reports and raw sequence datasets, ensuring transparency and utility for public health authorities. This subcontract, categorized under NAICS code 541620 for scientific research and development services, is issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services. The opportunity was posted on August 4, 2026, with a firm response deadline of August 10, 2026. While no specific location for performance or point of contact is provided, the deliverables are intended to support a national public health infrastructure, emphasizing rapid data turnaround and rigorous quality control to enable timely responses to viral outbreaks.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Warranty and Preventive Maintenance SupportThe contract provides warranty coverage and optional preventive maintenance services for solvent evaporation units under a subcontract arrangement, with coverage spanning one to two years. The work is specifically targeted at ensuring the continued operational reliability of these units through scheduled maintenance and repair support, with performance expected to occur in Denver. The solicitation, posted by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, is classified under NAICS code 811212, which relates to industrial and commercial equipment repair and maintenance. Responses must be submitted by August 10, 2026, with no set-asides specified for small businesses or other categories, and the contracting office has not provided a point of contact for inquiries.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Training for FDA Laboratory PersonnelThe contract involves providing hands-on training to FDA laboratory personnel on the operation, maintenance, and safety protocols for newly installed solvent evaporation systems. The training must be delivered in person at the designated place of performance in Denver and is intended to ensure that FDA staff are fully competent and compliant with all procedural and safety requirements associated with the equipment. The work is classified under NAICS code 611430, indicating it falls under professional and technical training services. The opportunity was posted on August 4, 2026, with a response deadline of August 10, 2026, and is structured as a subcontract under the Department of Health and Human Services, specifically managed by the FDA Office of Acquisition and Grant Services. The procurement does not specify a set-aside type or additional organizational details, and the point of contact information is not provided.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Installation and Commissioning of Evaporation SystemsThe contract involves the on-site installation, calibration, and performance verification of two solvent evaporation units at the FDA facility in Denver, Colorado. The work requires precise technical execution to ensure the systems operate within specified parameters for regulatory compliance and operational efficiency. All activities must be completed at the designated location, with no provision for off-site preparation or remote handling. The contract is classified as a subcontract under NAICS code 811212, indicating it pertains to industrial machinery and equipment repair and maintenance services. The opportunity was posted on August 4, 2026, with a strict response deadline of August 10, 2026, at 6:00 PM, leaving a narrow window for interested parties to submit proposals. The procuring entity is the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, emphasizing the critical nature of the equipment for federal regulatory functions. There is no set-aside designation provided, meaning all eligible subcontractors may compete for this award.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Supply of Solvent Evaporation Systems (Standard Model)The contract is for the procurement and delivery of one standard solvent evaporation system intended for routine sample preparation workflows, classified under NAICS code 333318, which corresponds to laboratory machinery and equipment manufacturing. This is a subcontract issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, with performance required in Denver. The solicitation was posted on August 4, 2026, and responses are due by 6:00 PM ET on August 10, 2026. The system must meet standard specifications for reliable, repeatable solvent removal in laboratory environments, supporting consistent analytical sample preparation. No set-aside designation is specified, indicating the opportunity is open to all eligible contractors without preference for small businesses or other categories. The contract does not include detailed contact information, and all submission and evaluation processes must be handled through the provided SAM.gov portal link.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Supply of Solvent Evaporation Systems (High-Throughput Model)The contract is for the procurement and delivery of a high-throughput solvent evaporation system designed specifically for HPLC/LC-MS/MS sample preparation, intended to replace aging and obsolete equipment. The system must meet stringent performance requirements to ensure accurate, efficient, and reliable sample processing in a high-volume analytical environment. The solicitation is issued under the NAICS code 333318, indicating it relates to laboratory machinery and equipment manufacturing, and is structured as a subcontract under the Department of Health and Human Services’ FDA Office of Acquisition and Grant Services. The place of performance is specified as Denver, with a clear deadline for responses set for August 10, 2026, at 6:00 PM. The posting date indicates the opportunity was made available on August 4, 2026, granting potential vendors a brief six-day window to submit proposals. No set-aside provisions or additional organizational details are provided, implying the contract is open to qualified suppliers without specific socioeconomic restrictions. The procurement aims to modernize laboratory capabilities critical to the FDA’s analytical operations.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Digital Collections Management: Alma Digital Module

Department Of Commerce Noaa

POSTED

DEADLINE

Packaging, Certification, and Logistics for Analytical StandardsThe contract requires comprehensive final packaging, cold chain logistics, certificate of analysis (COA) management, and secure shipment of analytical reference standards to the FDA Denver Laboratory, ensuring all materials maintain their integrity through transit via dry ice or cold packs. The work must adhere to strict temperature controls and documentation standards to meet regulatory requirements, with all packaging and labeling protocols designed to support the stability and traceability of the standards during transport. This subcontract, issued under the NAICS code 493190 by the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services, is targeted for performance at the Denver 80225 location. The solicitation was posted on August 4, 2026, with responses due by August 7, 2026, and no set-aside type has been designated. The scope demands precision in handling, certification, and delivery, with full accountability throughout the process to ensure compliance with federal laboratory standards for analytical reference materials.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Custom Multi-Component Veterinary Drug Reference Standards (Amphenicols, Avermectins, Nitroimidazoles, Quinolones, Fluoroquinolones)The contract calls for the production of ISO 17034-certified reference standards targeting multiple veterinary drug classes, including chloramphenicol, ivermectin, metronidazole, and enrofloxacin, encompassing amphenicols, avermectins, nitroimidazoles, and fluoroquinolones. Each class will be delivered in two certified lots, designated as ICV and CCV, with each lot consisting of five 1mL ampules, ensuring consistent, traceable, and analytically validated materials for regulatory and laboratory use. Full analytical documentation must accompany each batch, confirming identity, purity, concentration, and stability in accordance with international metrological standards for reference materials. The work is to be performed at a facility located in Denver, Colorado, with a strict submission deadline of August 7, 2026, and is issued under a subcontract arrangement by the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services. The North American Industry Classification System code 325412 confirms the manufacturing focus on pharmaceutical preparations, emphasizing the technical and regulatory rigor expected from the vendor to meet federal standards for reference standards used in veterinary drug testing and compliance monitoring.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Custom Multi-Component Veterinary Drug Reference Standards (Sulfonamides)The contract involves the manufacture of two certified lots of multi-component sulfonamide reference standards for veterinary drug applications, each consisting of five 1mL ampules with precisely defined concentration ratios aligned to government-specified tables. The materials must be produced to meet stringent quality and stability requirements, including a minimum shelf life of 12 months at the time of shipment, ensuring long-term usability for regulatory and testing purposes. The standards are designated as ICV and CCV, indicating their use as independent calibration and control verification materials critical to analytical validation and compliance. The work is being procured by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, with performance expected to occur in Denver, Colorado, and classified under NAICS code 325414 for pharmaceutical and botanical product manufacturing. Submission of proposals is due by August 7, 2026, and the contract is structured as a subcontract, suggesting it may follow an overarching government agreement. All output must adhere to exacting specifications to support federal laboratory and inspection protocols, with no flexibility permitted in composition, packaging, or stability validation.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Custom Multi-Component Veterinary Drug Reference Standards (Macrolides)The contract involves the production of ISO 17034-certified reference standards for macrolide antibiotics, specifically including Virginiamycin M1, to be delivered in two certified lots designated as ICV and CCV. Each lot will consist of five 1mL glass ampules, prepared under strict quality control to ensure purity, stability, and consistency suitable for use in LC-MS method calibration within veterinary drug testing. Full traceability of materials, processes, and analytical data is required, with each ampule accompanied by a detailed Certificate of Analysis that verifies identity, concentration, homogeneity, and stability under specified conditions. The standards must comply with international metrological requirements to support reliable analytical results in regulatory and diagnostic labs. The work is solicited as a subcontract under the Department of Health and Human Services, specifically managed by the FDA Office of Acquisition and Grant Services, with performance based in Denver, Colorado, 80225. The solicitation was posted on August 4, 2026, and responses are due by August 7, 2026, indicating a tight turnaround for technical proposal submission. The NAICS code 325412 classifies this as pharmaceutical and medicine manufacturing, underscoring the need for specialized expertise in reference material production. Deliverables must meet the highest regulatory benchmarks for certification, ensuring that the reference materials are fit for use in compliance testing, quality assurance, and method validation across veterinary drug monitoring programs.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Custom Multi-Component Veterinary Drug Reference Standards (NSAIDs)The contract entails the manufacture and delivery of ISO 17034-certified analytical reference standards specifically for nonsteroidal anti-inflammatory drugs (NSAIDs) to support veterinary drug residue testing. Two certified lots—intermediate control verification (ICV) and candidate control verification (CCV)—will be produced, each containing five 1mL glass ampules sealed for stability and purity. The reference standards are to be dissolved in LC-MS grade solvents to ensure compatibility with high-performance liquid chromatography and mass spectrometry workflows. All materials must meet rigorous certification standards to guarantee accuracy, traceability, and consistency in quantitative analytical applications. The work is required to be completed under a subcontract with a response deadline of August 7, 2026, and the place of performance is designated as Denver, Colorado, with a zip code of 80225. The contracting entity is the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, operating under NAICS code 325414, which corresponds to pharmaceutical preparation manufacturing. The deliverables are critical for laboratory quality control and regulatory compliance in animal health testing, requiring strict adherence to certification protocols and documentation without compromising sample integrity or analytical validity.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE